A detailed history of Toroso Investments, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Toroso Investments, LLC holds 17,447 shares of BMRN stock, worth $1.44 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
17,447
Previous 10,541 65.52%
Holding current value
$1.44 Million
Previous $1.02 Million 49.9%
% of portfolio
0.03%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$83.81 - $99.0 $578,791 - $683,694
6,906 Added 65.52%
17,447 $1.52 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $4,192 - $5,418
55 Added 0.52%
10,541 $1.02 Million
Q3 2023

Nov 15, 2023

BUY
$85.07 - $94.48 $48,319 - $53,664
568 Added 5.73%
10,486 $927,000
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $325,916 - $377,128
3,760 Added 61.06%
9,918 $860,000
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $34,043 - $45,500
388 Added 6.72%
6,158 $599,000
Q4 2022

Feb 15, 2023

BUY
$80.93 - $108.63 $58,188 - $78,104
719 Added 14.23%
5,770 $597,000
Q3 2022

Nov 23, 2022

BUY
$82.16 - $96.94 $23,333 - $27,530
284 Added 5.96%
5,051 $428,000
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $1,787 - $2,171
-25 Reduced 0.52%
4,767 $395,000
Q1 2022

May 20, 2022

BUY
$74.28 - $92.69 $35,208 - $43,935
474 Added 10.98%
4,792 $369,000
Q4 2021

Feb 16, 2022

BUY
$71.72 - $91.47 $14,630 - $18,659
204 Added 4.96%
4,318 $381,000
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $48,974 - $55,982
655 Added 18.94%
4,114 $318,000
Q2 2021

Aug 13, 2021

SELL
$75.51 - $84.79 $1,887 - $2,119
-25 Reduced 0.72%
3,459 $289,000
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $76,448 - $92,775
1,023 Added 41.57%
3,484 $263,000
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $178,693 - $221,982
2,461 New
2,461 $216,000
Q3 2020

Nov 16, 2020

SELL
$71.87 - $131.03 $118,801 - $216,592
-1,653 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$79.55 - $124.22 $131,496 - $205,335
1,653 New
1,653 $204,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.